DANBURY, Conn.--(BUSINESS WIRE)--
IMS Health Holdings, Inc. (“IMS Health”) (NYSE:IMS) will issue its
third-quarter 2015 financial results before the market opens on
Thursday, October 29, 2015. The earnings release and accompanying
financial information will be posted on the IMS Health Investor
Relations website at http://ir.imshealth.com.
IMS Health’s management team will host a conference call and webcast to
discuss the company’s results at 9:00 a.m. Eastern Time on October 29.
Interested parties are invited to listen to the live event and view the
presentation slides via webcast on IMS Health’s Investor Relations
website at http://ir.imshealth.com.
The discussion also will be available by dialing +1-800-926-9175 in the
U.S. and Canada, or +1-212-231-2920 for international callers.
A replay of the webcast will be available approximately two hours after
the conclusion of the live event on October 29. To access the webcast
recording, visit http://ir.imshealth.com.
About IMS Health
IMS Health is a leading global information and technology services
company providing clients in the healthcare industry with end-to-end
solutions to measure and improve their performance. Our 7,500 services
experts connect configurable SaaS applications to 10+ petabytes of
complex healthcare data in the IMS One™ cloud platform,
delivering unique insights into diseases, treatments, costs and
outcomes. The company’s 15,000 employees blend global consistency and
local market knowledge across 100 countries to help clients run their
operations more efficiently. Customers include pharmaceutical, consumer
health and medical device manufacturers and distributors, providers,
payers, government agencies, policymakers, researchers and the financial
As a global leader in protecting individual patient privacy, IMS Health
uses anonymous healthcare data to deliver critical, real-world disease
and treatment insights. These insights help biotech and pharmaceutical
companies, medical researchers, government agencies, payers and other
healthcare stakeholders to identify unmet treatment needs and understand
the effectiveness and value of pharmaceutical products in improving
overall health outcomes. Additional information is available at www.imshealth.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151015006669/en/
Source: IMS Health Holdings, Inc.